The d ıagnostıc Value of Serum autotaxın Level ın Colorectal Cancer
Conditions: Colo-rectal Cancer Interventions: Other: Serum autotax ın levels Sponsors: Diskapi Yildirim Beyazit Education and Research Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials

Feasibility of the Maastro Applicator in Rectal Cancer
Conditions: Rectal Cancer; Feasibility; Toxicity; Quality of Life; Radiation Toxicity; Radiation Proctitis; Brachytherapy; Complete Response Interventions: Device: Maastro applicator Sponsors: Maastricht Radiation Oncology; Varian Medical Systems Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials

Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR Targeted Therapy
Conditions: Metastatic Colorectal Adenocarcinoma Sponsors: Assiut University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials

Does the Management of Anastomotic Leakage After Low Rectal Resection Affect Survival
Conditions: Rectal Cancer; Anastomotic Leak Interventions: Other: Anastomotic leakage Sponsors: Cantonal Hospital of St. Gallen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials

Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life
Conditions:   Rectal Cancer;   Low Anterior Resection Syndrome Intervention:   Behavioral: LARS score/ EORTC QLQ C30 Sponsor:   University Hospital, Ghent Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials

PET/MRI in Rectal Cancer
Condition:   Rectal Cancer Interventions:   Radiation: Chemoradiation treatment;   Other: 18FDG-PET/MRI scan Sponsor:   AHS Cancer Control Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials

PET/MRI in Rectal Cancer
Conditions: Rectal Cancer Interventions: Radiation: Chemoradiation treatment; Other: 18FDG-PET/MRI scan Sponsors: AHS Cancer Control Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials

Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life
Conditions: Rectal Cancer; Low Anterior Resection Syndrome Interventions: Behavioral: LARS score/ EORTC QLQ C30 Sponsors: University Hospital, Ghent Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials

Evaluation of Surgical Complications and DFS in Obese Rectal Cancer Patients
Conditions: Obesity, Morbid; Rectal Cancer; Surgery-Complications Interventions: Procedure: BIB positioning Sponsors: Federico II University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
Condition:   Locally Advanced Rectal Cancer Interventions:   Drug: capecitabine;   Drug: tislelizumab;   Drug: thymalfasin;   Radiation: long-term radiotherapy Sponsors:   Beijing Friendship Hospital;   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Evaluation of Intra- and Peri-operative Complications and Disease-free Survival in Rectal Cancer Patients Undergoing Oncological Resective Surgery and Concomitant Bariatric Surgery
Condition:   Morbid Obesity; Rectal Cancer; Surgical Outcomes Intervention:   Procedure: BIB positioning Sponsor:   Federico II University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
Conditions: Locally Advanced Rectal Cancer Interventions: Drug: capecitabine; Drug: tislelizumab; Drug: thymalfasin; Radiation: long-term radiotherapy Sponsors: Beijing Friendship Hospital; Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

Evaluation of Intra- and Peri-operative Complications and Disease-free Survival in Rectal Cancer Patients Undergoing Oncological Resective Surgery and Concomitant Bariatric Surgery
Conditions: Morbid Obesity; Rectal Cancer; Surgical Outcomes Interventions: Procedure: BIB positioning Sponsors: Federico II University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors
Condition:   PARP Inhibitor for Esophageal Squamous Cell Carcinoma Intervention:   Drug: Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm)) Sponsor:   Chongqing University Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials